AQST ▼ -0.7% - Aquestive Therapeutics, Inc.
$AQST - Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027
15-OCT-2026 07:00 AM ET
Share this post
More filings for $AQST
AQST ▼ -4.5% - Aquestive Therapeutics, Inc.Nov 3, 2026AQST - Aquestive Therapeutics, Inc. - SEC Filing Update (07-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 7, 2026AQST - Aquestive Therapeutics, Inc. - SEC Filing Update (07-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 7, 2026AQST ▼ -2.1% - Aquestive Therapeutics, Inc.Sep 29, 2026AQST ▲ +1.4% - Aquestive Therapeutics, Inc.Sep 17, 2026AQST ▼ -0.2% - Aquestive Therapeutics, Inc.Sep 1, 2026
View full $AQST filing history →💬 Comments
Loading comments…
Leave a comment